Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study

被引：0
|
作者：
Etropolski, Mila
Shapiro, Douglas
Okamoto, Akiko
Rauschkolb-Loeffler, Christine
Haeussler, Juergen
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A217 / A218
页数：2
相关论文
共 50 条
  • [11] Efficacy and safety of oxcarbazepine in patients with neuropathic pain due to radiculopathy: A double-blind, randomized, placebo-controlled study
    Harden, RN
    Urniasz, KL
    Hopwood, M
    Wan, Y
    NEUROLOGY, 2005, 64 (06) : A120 - A121
  • [12] Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial
    Satoh, J.
    Yagihashi, S.
    Baba, M.
    Suzuki, M.
    Arakawa, A.
    Yoshiyama, T.
    Shoji, S.
    DIABETIC MEDICINE, 2011, 28 (01) : 109 - 116
  • [13] Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial
    Markman, John
    Resnick, Malca
    Greenberg, Scott
    Katz, Nathaniel
    Yang, Ruoyong
    Scavone, Joseph
    Whalen, Ed
    Gregorian, Gabriela
    Parsons, Bruce
    Knapp, Lloyd
    JOURNAL OF NEUROLOGY, 2018, 265 (12) : 2815 - 2824
  • [14] Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial
    John Markman
    Malca Resnick
    Scott Greenberg
    Nathaniel Katz
    Ruoyong Yang
    Joseph Scavone
    Ed Whalen
    Gabriela Gregorian
    Bruce Parsons
    Lloyd Knapp
    Journal of Neurology, 2018, 265 : 2815 - 2824
  • [15] Safety and Tolerability of Tapentadol Extended Release (ER) in Patients With Painful Diabetic Peripheral Neuropathy (DPN): Results of a Randomized-Withdrawal Phase 3 Study
    Etropolski, Mila
    Shapiro, Douglas
    Okamoto, Akiko
    Rauschkolb-loeffler, Christine
    Lange, Robert
    Haeussler, Juergen
    DIABETES, 2009, 58 : A226 - A227
  • [16] Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study
    Meier, T
    Wasner, G
    Faust, M
    Kuntzer, T
    Ochsner, F
    Hueppe, M
    Bogousslavsky, J
    Baron, R
    PAIN, 2003, 106 (1-2) : 151 - 158
  • [17] Efficacy and Safety of Dextromethorphan/Quinidine at Two Dosage Levels for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study
    Shaibani, Aziz I.
    Pope, Laura E.
    Thisted, Ronald
    Hepner, Adrian
    PAIN MEDICINE, 2012, 13 (02) : 243 - 254
  • [18] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [19] Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain
    Simpson, Richard W.
    Wlodarczyk, John H.
    DIABETES CARE, 2016, 39 (09) : 1493 - 1500
  • [20] A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
    Daniels, Stephen
    Casson, Ed
    Stegmann, Jens-Ulrich
    Oh, Charles
    Okamoto, Akiko
    Rauschkolb, Christine
    Upmalis, David
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (06) : 1551 - 1561
12345